Influence of Glutamine on the Growth of Human Glioma and Medulloblastoma in Culture

Cancer Research

Volumn 45, Issue 9, 1985, Pages 4077-4081

  Dranoff, Glenn ^a   Elion, Gertrude B ^a   Friedman, Henry S ^a   Le, Graham ^a   Campbell, M ^a   Bigner, Darell D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYLYSINE; 6 DIAZO 5 OXONORLEUCINE; ACIVICIN; AMINOADIPIC ACID; GLUTAMINE; METHIONINE SULFOXIME; METHIONINE SULFOXIMINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CELL CULTURE; CELL LINE; CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; GLIOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDULLOBLASTOMA; NERVOUS SYSTEM; PRIORITY JOURNAL;

2-AMINOADIPIC ACID; CELLS, CULTURED; DIAZOOXONORLEUCINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOMA; GLUTAMATE-AMMONIA LIGASE; GLUTAMINE; HUMANS; HYDROXYLYSINE; MEDULLOBLASTOMA;

EID: 0022357679     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bert, S., and Clarke, D. D. Compartmentation of amino acid metabolism. In: A. Lajtha (ed.), Handbook of Neurochemistry, Vol. 2, pp. 447-472. New York: Plenum Publishing Corp., 1969.
2. Bigner, D. D., Bigner, S. H., Pontèn, J., Westermark, B., Mahaley, M. S., Ruoslahti, E., Hershmann, H., Eng, L. F., and Wikstrand, C. J. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropathol. Exp. Neurol., 40: 201-229, 1981.
3. Bigner, D. D., Pedersen, H. B., Bigner, S. H., and McComb, R. A proposed basis for the therapeutic resistance of gliomas. Semin. Neurol., 1: 169-179, 1981.
4. Bigner, S. H., Mark, J., and Bigner, D. D. Karyotypic evolution of human glioblastoma multiforme during establishment in culture. Proc. Am. Assoc. Cancer Res., 25: 36, 1984.
5. Braunstein, A. E. Amino group transfer. In: P. O. Boyer (ed.), The Enzymes, Ed. 3, pp. 379-481. New York: Academic Press, 1975.
6. Campbell, G. L., Bartel, R., Friedman, H. S., and Bigner, D. D. Effects of glutamate analogs on brain tumor cell lines. J. Neurochem., in press, 1985.
7. Catane, R., Von Hoff, D. D., Glaubiger, D. L., and Muggia, F. M. Azaserine. DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity. Cancer Treat. Rep., 63: 1033-1038, 1979.
8. Charles, A. K., and Chang, Y.-F. Uptake, release, and metabolism of D- and L-α-aminoadipate by rat cerebral cortex. J. Neurochem., 36: 1127-1136, 1981.
9. Clinical Brochure, AT-125 (L-(aS-5S) -α-amino-3-chloro-4,5-dihydro-5-isoxa-zoleacetic acid) NSC 163501, April 1979.
10. Eagle, H., Oyama, V. I., Levy, M., Horton, C. L., and Fleischman, R. The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid. J. Biol. Chem., 218: 607-616, 1956.
11. Earhart, R. H., Koeller, J. M., Davis, T. E., Borden, E. C., McGovren, J. P., Davis, H. L., and Tormey, D. C. Phase I trial and pharmacokinetics of actvicin administered by 72-hour infusion. Cancer Treat. Rep., 67: 683-692, 1983.
12. Friedman, H. S., Bigner, S. H., McComb, R. D., Schold, S. C., Jr., Pasternak, J. F., Groothuis, D. R., and Bigner, D. D. A model for human medulloblastoma-growth, rnorphology, and chromosomal analysts in vitro and in athymic mice. J. Neuropathol. Exp. Neurol., 42: 485-503, 1983.
13. Giard, D. J., Aaronson, S. A., Todaro, G. J., Amstein, P., Kersey, J. H., Dosite, H., and Parks, W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst., 51: 1417-1423, 1973.
14. Gregersen, N., Brandt, N. J., Christensen, E., Gron, I., Rasmussen, K., and Brandt, S. Glutaric aciduria: clinical and laboratory findings in two brothers. J. Pediatr., 90: 740-745, 1977.
15. Jayaram, H. N., Cooney, D. A., Ryan, J. A., Neil, G., Dion, R. L., and Bono, V. H. L-[aS, 5S]-a-amino-3-chloro-4, 5-dihydro-5-isoxazoleacetic acid (NSC 163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamine. Cancer Chemother. Rep., 59: 481-491, 1975.
16. Krakoff, I. H. Effect of methionine sulfximine in man. Clin. Pharmacol. Ther., 2: 599-604, 1961.
17. Kvamme, E. Glutamine. In: A. Lajtha (ed.), Handbook of Neurochemistry, Vol. 3, pp. 405-422. New York: Plenum Publishing Corp., 1983.
18. Lucas, D. R., and Newhouse, J. P. The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch. Ophthalmol., 58: 193-201, 1957.
19. McAllister, R. M., Isaacs, H., Rongey, R., Peer, M., Au, W., Souteup, S. W., and Gardner, M. B. Establishment of a human medulloblastoma cell line. Int. J. Cancer, 20: 206-212, 1977.
20. McComb, R. D., and Bigner, D. D. Immunolocalization of laminin in neoplasms of the central and peripheral nervous systems. J. Neuropathol. Exp. Neurol., in press, 1985.
21. McGovern, J. P., Stewart, J. C., Elfring, G. L., Smith, R. B., Soares, N., Wood, J. H., Poplack, D. G., and Von Hoff, D. D. Plasma and cerebrospinal fluid pharmacoldnetics of acivtcin in Ommaya reservoir-bearing rhesus monkeys. Cancer Treat. Rep., 66: 1333-1341, 1982.
22. Meister, A. Catalytic mechanisms of glutamine synthetase; overview of glutamine metaboism. In: J. Mora and R. Patactos (eds.), Glutamine: Metabofem, Enzymotogy, and Regulation, pp. 1-40. New York: Academic Press, 1980.
23. Meister, A., and Griffith, O. W. Effects of methionine sulfoximine analogs on the synthesis of glutamine and glutathione: possible crtemotherapeutic implications. Cancer Treat. Rep., 63: 1115-1121, 1979.
24. Olney, J. W., Ho, O. L., and Rhee, V. Cytotoxic effects of acidic and sulphur containing amino acid on the infant mouse central nervous system. Exp. Brain Res., 14: 61-76. 1971.
25. Overjera, A. A., Houchens, D. P., Catane, R., Sheridan, M. A., and Muggia, F. M. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-ý-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice. Cancer Res., 39: 3220-3224, 1979.
26. Pilkington, G. J., and Lantos, P. L. The role of glutamine synthetase in the diagnosis of cerebral tumors. Neuropathol. Appl. Neurobiol., 8: 227-236, 1982.
27. Rum, C. M. Free amino acid levels in the cerebrospinal fluid of normal humans and their variation in cases of epilepsy and Spielmeyer-Vogt-Batten disease. J. Neurochem., 23: 595-600, 1974.
28. Prusiner, S. B. Disorders of glutamate metabolism and neurological dysfunction. Amu. Rev. Med., 32: 521-542, 1981.
29. Przyrembel, H., Bachman, D., Lombeck, I., Becker, K., Wendel, U., Wadman, S. K., and Bremer, H. J. Alpha-ketoadipic aciduria, a new inborn error of lysine metabolism; biochemical studies. Clin. Chim. Acta, 58: 257-269, 1975.
30. Rabinovitz, M., Olson, M. E., and Greenberg, D. M. 5-Hydroxylysine-an inhibitor of glutamine and protein synthesis by the Ehriich ascites carcinoma cell. Cancer Res., 17: 885-889, 1957.
31. Rahman, A., Luc, V., Smith, F. P., Brown, J., Schein P. S., and Wooley, P. V. Phase I trial and pharmacology of 6-diazo-5-oxo-norleucine (DON). Proc. Am. Assoc. Cancer Res., 22: 352, 1981.
32. Schaumberg, H. H., Byck, R., Gerstl, R., and Mashman, J. H. Monosodium L-glutamate: its pharmacology and role in the Chinese restaurant syndrome. Science (Wash. DC), 163: 826-828, 1969.
33. Shapiro, J. R., Yung, W. K. A., and Shapiro, W. R. Isolation, karyotype, and clonal growth of heterogeneous subpoputations of human malignant gliomas. Cancer Res., 41: 2349-2359. 1981.
34. Smith, E. L., Austen, B. M., Blumenthal, K. M., and Nye, J. F. Glutamate dehydrogenase. In: P. D. Boyer (ed.), The Enzymes, Vol. 11, pp. 293-367. New York: Academic Press, 1975.
35. Vick, N. A., Khandekar, J. D., and Bigner, D. D. Chemotherapy of brain tumors-the “blood-brain barrier is not a factor. Arch. Neurol., 34: 523-526, 1977.
36. Warren, R. P., Jr., Chou, T.-C., Gordon, C., Tan, C., Roberts, J., Sternberg, S. S., Philips, F. S., and Young, C. W. Phase I evaluation of succinyJated Acinetobacter glutaminase-asparaginase in adults. Cancer Res., 40: 4546-4551, 1980.
37. Weiss, G. R., McGovren, J. P., Schade, D., and Kufe, D. W. Phase I and pharmacological study of acivicin by 24-hour continuous infusion. Cancer Res., 42: 3892-3895, 1982.
38. Wikstrand, C. J., Bigner, S. H., and Bigner, D. D. Demonstration of complex antigenic heterogeneity in a human glioma cell Ine and eight denved clones by specific monoclonal antibodies. Cancer Res., 43: 3327-3334, 1983.
39. Zielke, H. R., Zielke, C. L., and Ozand, P. T. Glutamine: a major energy source for cultured mammalian cells. Fed. Proc., 43: 121-125, 1984.